M. Peluso

发表

The Fully human anti-CD47 antibody SRF231 exerts dual-mechanism antitumor activity via engagement of the activating receptor CD32a

Jonathan A. Hill, Benjamin H. Lee, V. Palombella, 2020, Journal for ImmunoTherapy of Cancer.

Impact of the Smoothened Inhibitor, IPI-926, on Smoothened Ciliary Localization and Hedgehog Pathway Activity

J. Kutok, M. Read, J. Proctor, 2014, PloS one.

The phosphoinositide-3-kinase (PI3K)-delta and gamma inhibitor, IPI-145 (Duvelisib), overcomes signals from the PI3K/AKT/S6 pathway and promotes apoptosis in CLL

V. Gandhi, J. Burger, M. Keating, 2015, Leukemia.

Duvelisib Eliminates CLL B Cells, Impairs CLL-Supporting Cells, and Overcomes Ibrutinib Resistance in Preclinical Models

J. Kutok, Yasmine Kieso, N. Chiorazzi, 2021 .

The Phosphoinositide-3-Kinase ( PI 3 K )-Delta and Gamma Inhibitor , IPI-145 , Overcomes Signals from the PI 3 K / AKT / S 6 Pathway and Promotes Apoptosis in CLL

V. Gandhi, J. Burger, M. Keating, 2015 .

Abstract 6639: SRF617, a potent enzymatic inhibitor of CD39, demonstrates single-agent activity and cooperates with various cancer therapies in both solid tumor and hematologic malignancies

A. Dulak, Benjamin H. Lee, V. Palombella, 2020 .

Results of a first-in-human phase I study of SRF231, a fully human, high-affinity anti-CD47 antibody.

A. Schram, M. Beeram, A. Patnaik, 2020 .

Duvelisib (IPI-145) Inhibits Malignant B-Cell Proliferation and Disrupts Signaling from the Tumor Microenvironment through Mechanisms That Are Dependent on PI3K-δ and PI3K-γ

D. Winkler, J. Kutok, H. Stern, 2014 .

The pre-clinical absorption, distribution, metabolism and excretion properties of IPI-926, an orally bioavailable antagonist of the hedgehog signal transduction pathway

Jeanne A. Ferguson, J. Sydor, J. Adams, 2013, Xenobiotica; the fate of foreign compounds in biological systems.

The Fully Human Anti-CD47 Antibody SRF231 Has Dual-Mechanism Antitumor Activity Against Chronic Lymphocytic Leukemia (CLL) Cells and Increases the Activity of Both Rituximab and Venetoclax

M. Davids, Benjamin H. Lee, V. Palombella, 2018, Blood.